Definitive Contract HT942525CE032
- Not listed
- This federal contract award is for a Small Business Innovation Research (SBIR) Phase I effort by Altrazeal Life Sciences Inc., doing business as Uluru, to develop an "Innovative Adaptive Drug Delivery System Enhanced Neuroprotection Repair Traumatic Brain Injuries from Penetrating Trauma Open Skull Fractures in Low Resource Envir." The $249,999.96 firm fixed-price contract was awarded by the Defense Health Agency (DHA) on October 7, 2024 and runs through May 6, 2025. The research is...
- This is a Small Business Innovation Research (SBIR) Phase II medical research and development contract awarded by the Defense Health Agency (DHA) to TDA Research, Inc., a small business subchapter S corporation located in Colorado. The contract, valued at $1,099,998.70, is for the development of a novel lightweight composite liner to complement a regular combat helmet with enhanced protection against blast and concussive forces. The contract was set aside for small businesses and has a...
- This is a $2,049,630.00 definitive contract awarded by the Defense Health Agency (DHA) to Triton Systems, Inc., a small business, for a SBIR Phase II project titled "INSTANT INJURY IMMOBILIZATION FOR TEMPORARY RETURN TO DUTY". The contract has a period of performance through August 14, 2026. As a Small Business Innovation Research (SBIR) Phase II award, this contract continues the development of a technology that was previously demonstrated in a Phase I effort. The project aims to...
- This is a $2,994,281.25 Firm Fixed Price contract awarded by the Defense Health Agency (DHA) to Paranano Wound Care LLC, a small business, under the SBIR (Small Business Innovation Research) program. The contract is for Phase II of a project titled "The BIOZ Smart Bandage Empowering Priority Response to Pathogen Invasion in Wounds" and has an ultimate completion date of July 11, 2027. The contract is focused on medical research and development related to wound care and pathogen...
- The Defense Health Agency awarded a $3.0 million Phase II Small Business Innovation Research (SBIR) contract to Technology Holding LLC, a small business based in Salt Lake City, Utah, for the development of a novel biologic countermeasure for acute radiation syndrome. This 23-month effort, which commenced on June 21, 2022, and concludes October 20, 2026, is structured as a firm fixed-price definitive contract under the SBIR program's Phase II action, which supports innovative research and...
- This is a $2,999,629 firm fixed price contract awarded by the Defense Advanced Research Projects Agency (DARPA) to The Ultran Group, Inc., a small business manufacturer of ultrasound technologies. The contract is for the development of a wearable ultrasonic device for patient self-administered treatment of inflammation, under DARPA's Small Business Innovation Research (SBIR) Program Phase II. The contract was set aside for small businesses and has an ultimate completion date of July 12, 2025....
- This is a firm fixed-price definitive contract awarded by the Defense Health Agency (DHA) to Ultradiagnostics Inc. for the development of a portable ultrasound system capable of transcranial imaging to assess traumatic brain injury (TBI). The contract, with a ceiling value of $4,503,258.06, was originally awarded on September 15, 2015 under the Joint Warfighter Medical Research Program (JWMRP) and had an initial period of performance through May 31, 2023. The contract is now being modified on...
- This is a Small Business Innovation Research (SBIR) Phase II medical research and development contract awarded by the Defense Health Agency (DHA) to TDA Research, Inc., a for-profit small business located in Colorado. The $1,499,999.00 firm-fixed-price contract is for the development of "Technology for Genitourinary Tissue Repair." The contract has a completion date of October 18, 2025. TDA Research has subcontracted work to two entities: Duquesne University, a private non-profit...
- This is a $249,996.23 Firm Fixed Price contract awarded by the Defense Health Agency (DHA) to TDA Research, Inc., a small business located in Wheat Ridge, Colorado. The contract is for Phase I of the DHA's Small Business Innovation Research (SBIR) program, and is focused on developing an "Enhanced Combat Tourniquet with Modular Wound Infection Prevention Capabilities." This SBIR Phase I effort aims to advance a medical device that can aid in combat casualty care. TDA Research...
- The Defense Health Agency (DHA) has awarded a $1,099,913.06 Small Business Innovation Research (SBIR) Phase II contract to Triton Systems, Inc., a small business prime contractor based in Chelmsford, Massachusetts. The contract is for the development of "Adaptive Technology to Optimize Rehabilitation of Lower Extremity Musculoskeletal Injuries." This research and development effort supports the DHA's medical technology objectives. The contract has a completion date of December 28, 2025...
The Defense Health Agency awarded a $1.3 million Small Business Innovation Research (SBIR) Phase II contract to Altrazeal Life Sciences Inc., doing business as Uluru, on September 5, 2025. This firm fixed-price contract supports the development of an innovative and adaptive drug delivery system designed to enhance neuroprotection and repair in traumatic brain injuries resulting from penetrating trauma or open skull fractures in low-resource environments. The work will be performed at the contractor's facility in Addison, Texas, with an ultimate completion date of January 4, 2028. As a small business set-aside award, this contract reflects the Defense Health Agency's commitment to leveraging innovative solutions from small businesses to address critical military medical challenges. Altrazeal Life Sciences, a medical equipment manufacturer specializing in drug delivery solutions and trauma care technologies based in Addison, Texas, has demonstrated sustained expertise in developing advanced medical technologies for federal defense applications. This Phase II award builds on the company's prior SBIR Phase I research and represents part of a broader portfolio of federally-funded medical technology initiatives focused on trauma treatment and wound management. The contract supports the company's mission to create cutting-edge solutions that address complex healthcare challenges in military and austere care settings, contributing to improved outcomes for service members and trauma patients in resource-constrained environments.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3m | 9/3/25 |